Comparison of WHO, RECIST 1.1, EORTC, and PERCIST criteria in the evaluation of treatment response in malignant solid tumors.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To compare response assessment according to the WHO, RECIST 1.1, EORTC, and PERCIST criteria in patients diagnosed with malignant solid tumors and who had received cytotoxic chemotherapy to establish the strength of agreement between each criterion.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Nucl Med Commun

Title: Nuclear medicine communications

Publisher: Ovid Technologies (Wolters Kluwer Health)

ISSN (Electronic): 1473-5628

ISSN (Print): 0143-3636

Publication date (Electronic): Jan 2016

Volume: 37

Issue: 1

Affiliations

[1 ] aDepartment of Nuclear Medicine, Bulent Ecevit University School of Medicine, Zonguldak Departments of bNuclear Medicine cMedical Oncology, Marmara University School of Medicine, Istanbul dDepartment of Nuclear Medicine, Recep Tayyip Erdogan University School of Medicine, Rize, Turkey.

Article

DOI: 10.1097/MNM.0000000000000401

PubMed ID: 26440568

SO-VID: 28882fee-91e2-46ec-b44c-44573665e146

History

Data availability:

Comments

Comment on this article

scite_

Cited by 33

See all cited by